Your browser doesn't support javascript.
loading
Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.
Simpson, E L; Lacour, J-P; Spelman, L; Galimberti, R; Eichenfield, L F; Bissonnette, R; King, B A; Thyssen, J P; Silverberg, J I; Bieber, T; Kabashima, K; Tsunemi, Y; Costanzo, A; Guttman-Yassky, E; Beck, L A; Janes, J M; DeLozier, A M; Gamalo, M; Brinker, D R; Cardillo, T; Nunes, F P; Paller, A S; Wollenberg, A; Reich, K.
Afiliação
  • Simpson EL; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
  • Lacour JP; Department of Dermatology, University Hospital of Nice, Nice, France.
  • Spelman L; Veracity Clinical Research, Brisbane, Australia.
  • Galimberti R; Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Eichenfield LF; University of California, San Diego and Rady Children's Hospital, San Diego, CA, USA.
  • Bissonnette R; Innovaderm Research, Montreal, QC, Canada.
  • King BA; Yale University School of Medicine, New Haven, CT, USA.
  • Thyssen JP; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Silverberg JI; Department of Dermatology George Washington University School of Medicine, Washington, DC, USA.
  • Bieber T; Department of Dermatology and Allergy, University of Bonn, Bonn, Germany.
  • Kabashima K; Department of Dermatology, Kyoto University, Kyoto, Japan.
  • Tsunemi Y; Department of Dermatology, Saitama Medical University, Saitama, Japan.
  • Costanzo A; Humanitas University and Dermatology Unit, Humanitas Research Hospital, Milan, Italy.
  • Guttman-Yassky E; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Beck LA; Department of Dermatology, University of Rochester Medical Center, Rochester, NY, USA.
  • Janes JM; Lilly Research Laboratory, Eli Lilly and Company, Indianapolis, IN, USA.
  • DeLozier AM; Lilly Research Laboratory, Eli Lilly and Company, Indianapolis, IN, USA.
  • Gamalo M; Lilly Research Laboratory, Eli Lilly and Company, Indianapolis, IN, USA.
  • Brinker DR; Lilly Research Laboratory, Eli Lilly and Company, Indianapolis, IN, USA.
  • Cardillo T; Lilly Research Laboratory, Eli Lilly and Company, Indianapolis, IN, USA.
  • Nunes FP; Lilly Research Laboratory, Eli Lilly and Company, Indianapolis, IN, USA.
  • Paller AS; Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Wollenberg A; Department of Dermatology and Allergology, Ludwig Maximillian University, Munich, Germany.
  • Reich K; Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Skinflammation® Center, Hamburg, Germany.
Br J Dermatol ; 183(2): 242-255, 2020 08.
Article em En | MEDLINE | ID: mdl-31995838
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos